Phibro Animal Health Corporation (PAHC) Free cash flow 2017–2026
Phibro Animal Health Corporation (PAHC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$9.9MFY2026 · since FY2017: $77.5M → $9.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $9.9M | -76.4% |
| FY2025 | $41.8M | -9.8% |
| FY2024 | $46.4M | +220.5% |
| FY2023 | -$38.5M | -613.3% |
| FY2022 | -$5.4M | -128.4% |
| FY2021 | $19.0M | -25.0% |
| FY2020 | $25.3M | +46.4% |
| FY2019 | $17.3M | -66.4% |
| FY2018 | $51.5M | -33.6% |
| FY2017 | $77.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PAHC financial trends
PAHC RevenuePAHC Net incomePAHC Net marginPAHC Gross profitPAHC Gross marginPAHC Operating incomePAHC Operating marginPAHC Operating cash flowPAHC Capital expendituresPAHC Return on equityPAHC Stock buybacksPAHC Dividends paidPAHC Total assetsPAHC Total liabilitiesPAHC Shareholders’ equityPAHC overview →